Skip to main content
Top
Published in: Inflammation 3/2013

01-06-2013

Association of Body Fat with Inflammation in Peritoneal Dialysis

Authors: Andresa Marques de Mattos, Paula Payão Ovidio, Alceu Afonso Jordão, José Abrão Cardeal da Costa, Paula Garcia Chiarello

Published in: Inflammation | Issue 3/2013

Login to get access

Abstract

Peritoneal dialysis (PD) frequently leads to body weight gain, which appears to be a potential cause of the chronic inflammation frequently present in these patients. The consequences of this inflammation are impaired nutritional status, accelerated atherosclerosis, and increased mortality. To assess the association between inflammation and body fat in female patients treated with PD. Nineteen female patients on PD for at least 6 months with no infectious complications or malignant or acute inflammatory diseases. Nutritional status was determined by measuring weight, height, body mass index (BMI), waist (WC), and mid-arm circumferences (MAC), mid-arm muscle area, and tricipital fold (TCF). Bioelectrical impedance (BIA) was used to determine body composition. Biochemical evaluation included the determination of serum albumin, urea, creatinine, and C-reactive protein (CRP). The glucose absorbed from the dialysis solution was quantitated. According to BMI, two patients were classified as malnourished and ten as overweight/obese. Sixteen individuals had high WC measurements and 12 had excess body fat (BF) as measured by BIA. High CRP levels were observed in 12 patients, who had higher WC, MAC, BMI, TCF, and BF measurements compared to non-inflamed patients. Positive associations were detected between CRP and BMI, MAC, WC, and TCF. Associations between BF and CRP suggest that adiposity may be a potent exacerbating factor of inflammation in this population, especially visceral fat. Thus, obesity may be considered to be one more factor responsible for the early atherosclerosis and high cardiovascular mortality observed in these patients.
Literature
1.
go back to reference Carvalho, L.K., M.I.B. Silva, B.S. Vale, R. Bregman, R.B. Martucci, J.J. Carerro, et al. 2011. Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients stages 3 and 4: a longitudinal study. Nephrology Dialysis Transplantation 0: 1–6. Carvalho, L.K., M.I.B. Silva, B.S. Vale, R. Bregman, R.B. Martucci, J.J. Carerro, et al. 2011. Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients stages 3 and 4: a longitudinal study. Nephrology Dialysis Transplantation 0: 1–6.
2.
go back to reference Axelsson, J., A.R. Qureshi, M.E. Suliman, H. Honda, R. Pecoits-Filho, O. Heimbürger, et al. 2004. Truncal fat mass as a contributor to inflammation in end-stage renal disease. The American Journal of Clinical Nutrition 80: 1222–1229.PubMed Axelsson, J., A.R. Qureshi, M.E. Suliman, H. Honda, R. Pecoits-Filho, O. Heimbürger, et al. 2004. Truncal fat mass as a contributor to inflammation in end-stage renal disease. The American Journal of Clinical Nutrition 80: 1222–1229.PubMed
3.
go back to reference Lai, K.N., and J.C.K. Leung. 2010. Inflammation in peritoneal dialysis. Nephron Clinical Practice 116: 11–18.CrossRef Lai, K.N., and J.C.K. Leung. 2010. Inflammation in peritoneal dialysis. Nephron Clinical Practice 116: 11–18.CrossRef
4.
go back to reference Lai, K.N., and J.C.K. Leung. 2010. Peritoneal adipocytes and their role in inflammation during peritoneal dialysis. Mediators of Inflammation 2010: 1–10.CrossRef Lai, K.N., and J.C.K. Leung. 2010. Peritoneal adipocytes and their role in inflammation during peritoneal dialysis. Mediators of Inflammation 2010: 1–10.CrossRef
5.
go back to reference Nihi, M.M., R.C. Manfro, C. Martins, M. Suliman, Y. Murayama, M.C. Riella, et al. 2010. Association between body fat, inflammation and oxidative stress in hemodialysis. Jornal Brasileiro de Nefrologia 32(1): 11–17.CrossRef Nihi, M.M., R.C. Manfro, C. Martins, M. Suliman, Y. Murayama, M.C. Riella, et al. 2010. Association between body fat, inflammation and oxidative stress in hemodialysis. Jornal Brasileiro de Nefrologia 32(1): 11–17.CrossRef
6.
go back to reference Ramos, L.F., A. Shintani, T.A. Ikizler, and J. Himmelfarb. 2008. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. Journal of the American Society of Nephrology 19: 593–599.PubMedCrossRef Ramos, L.F., A. Shintani, T.A. Ikizler, and J. Himmelfarb. 2008. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. Journal of the American Society of Nephrology 19: 593–599.PubMedCrossRef
7.
go back to reference Kaysen, G.A., P. Kotanko, F. Zhu, S.R. Sarkar, S.B. Heymsfield, M.K. Kuhlmann, et al. 2009. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. Journal of Renal Nutrition 19(5): 357–364.PubMedCrossRef Kaysen, G.A., P. Kotanko, F. Zhu, S.R. Sarkar, S.B. Heymsfield, M.K. Kuhlmann, et al. 2009. Relationship between adiposity and cardiovascular risk factors in prevalent hemodialysis patients. Journal of Renal Nutrition 19(5): 357–364.PubMedCrossRef
8.
go back to reference Berbel, M.N., M.P.R. Pinto, D. Ponce, and A.L. Balbi. 2011. Nutritional aspects in acute kidney injury. Revista da Associação Médica Brasileira 57(5): 587–592.CrossRef Berbel, M.N., M.P.R. Pinto, D. Ponce, and A.L. Balbi. 2011. Nutritional aspects in acute kidney injury. Revista da Associação Médica Brasileira 57(5): 587–592.CrossRef
9.
go back to reference Kamimura, M.A., S.A. Draibe, D.M. Sigulem, and L. Cuppari. 2004. Methods of body composition assessment in patients undergoing hemodialysis. Revista de Nutrição 17(1): 97–105.CrossRef Kamimura, M.A., S.A. Draibe, D.M. Sigulem, and L. Cuppari. 2004. Methods of body composition assessment in patients undergoing hemodialysis. Revista de Nutrição 17(1): 97–105.CrossRef
10.
go back to reference Lipschitz, D.A. 1994. Screening for nutritional status in the elderly. Primary Care 21(1): 55–67.PubMed Lipschitz, D.A. 1994. Screening for nutritional status in the elderly. Primary Care 21(1): 55–67.PubMed
11.
go back to reference Frisancho, A.R. 1981. New norms of upper limb fat and muscle areas for assessment of nutritional status. The American Journal of Clinical Nutrition 34: 2540–2545.PubMed Frisancho, A.R. 1981. New norms of upper limb fat and muscle areas for assessment of nutritional status. The American Journal of Clinical Nutrition 34: 2540–2545.PubMed
12.
go back to reference Heyward, V.H., and D.R. Wagner. 2004. Applied body composition assessment, 2nd ed. Champaign: Human Kinetics. Heyward, V.H., and D.R. Wagner. 2004. Applied body composition assessment, 2nd ed. Champaign: Human Kinetics.
13.
go back to reference National Kidney Foundation. 2000. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. American Journal of Kidney Diseases 35(6): 1–3.CrossRef National Kidney Foundation. 2000. K/DOQI clinical practice guidelines for nutrition in chronic renal failure. American Journal of Kidney Diseases 35(6): 1–3.CrossRef
14.
go back to reference Daugirdas JT. 1994. Prescrição de hemodiálise crônica: Uma abordagem da cinética da uréia, 86–113 Mesi, Belo Horizonte, Brasil Daugirdas JT. 1994. Prescrição de hemodiálise crônica: Uma abordagem da cinética da uréia, 86–113 Mesi, Belo Horizonte, Brasil
15.
go back to reference National Kidney Foundation. 1997. K/DOQI clinical practice guidelines for peritoneal dialysis adequacy. American Journal of Kidney Diseases 30: 67–136.CrossRef National Kidney Foundation. 1997. K/DOQI clinical practice guidelines for peritoneal dialysis adequacy. American Journal of Kidney Diseases 30: 67–136.CrossRef
16.
go back to reference Nascimento, M.M., R. Pecoits-Filho, A.R. Qureshi, et al. 2004. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrology Dialysis Transplantation 19: 2803–2809.CrossRef Nascimento, M.M., R. Pecoits-Filho, A.R. Qureshi, et al. 2004. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrology Dialysis Transplantation 19: 2803–2809.CrossRef
17.
go back to reference SAS/STAT® User’s Guide, Version 9.0, Cary, NC, USA: SAS Institute Inc., 2002. SAS/STAT® User’s Guide, Version 9.0, Cary, NC, USA: SAS Institute Inc., 2002.
18.
go back to reference Chow, V.C., R.M. Yong, A.L. Li, C.W. Lee, E.H. Ho, C.K. Chan, et al. 2003. Nutritional requirements and actual dietary intake of continuous ambulatory peritoneal dialysis patients. Peritoneal Dialysis International 23(S2): 52–54. Chow, V.C., R.M. Yong, A.L. Li, C.W. Lee, E.H. Ho, C.K. Chan, et al. 2003. Nutritional requirements and actual dietary intake of continuous ambulatory peritoneal dialysis patients. Peritoneal Dialysis International 23(S2): 52–54.
19.
go back to reference Johnson, D.W. 2007. What is the optimal fat mass in peritoneal dialysis patients? Peritoneal Dialysis International 27(S2): 250–254. Johnson, D.W. 2007. What is the optimal fat mass in peritoneal dialysis patients? Peritoneal Dialysis International 27(S2): 250–254.
20.
go back to reference Wankowicz, Z. 2009. Peritoneal dialysis and its role in the demography and epidemiology of chronic kidney disease. Polskie Archiwun Medycyny Wewnetrznej 119(12): 810–813. Wankowicz, Z. 2009. Peritoneal dialysis and its role in the demography and epidemiology of chronic kidney disease. Polskie Archiwun Medycyny Wewnetrznej 119(12): 810–813.
21.
go back to reference Park, S.H., and B. Lindholm. 2009. Definition of metabolic syndrome in peritoneal dialysis. Peritoneal Dialysis International 29(S2): 137–144. Park, S.H., and B. Lindholm. 2009. Definition of metabolic syndrome in peritoneal dialysis. Peritoneal Dialysis International 29(S2): 137–144.
22.
go back to reference Di Gioia, M.C., P. Gallar, I. Rodriguez, N. Laso, R. Callejas, and Ortega. 2012. Changes in body composition parameters in patients on haemodialysis and peritoneal dialysis. Nefrología 32(1): 108–113. Di Gioia, M.C., P. Gallar, I. Rodriguez, N. Laso, R. Callejas, and Ortega. 2012. Changes in body composition parameters in patients on haemodialysis and peritoneal dialysis. Nefrología 32(1): 108–113.
23.
go back to reference Su, W.S., C.M. Clase, K.S. Brimble, P.J. Margetts, T.J. Wilkieson, and A.S. Gangji. 2010. Waist-to-hip ratio, cardiovascular outcomes, and death in peritoneal dialysis patients. The International Journal of Pediatric Nephrology 2010: 1–5.CrossRef Su, W.S., C.M. Clase, K.S. Brimble, P.J. Margetts, T.J. Wilkieson, and A.S. Gangji. 2010. Waist-to-hip ratio, cardiovascular outcomes, and death in peritoneal dialysis patients. The International Journal of Pediatric Nephrology 2010: 1–5.CrossRef
24.
go back to reference Wang, X., J. Axelsson, L. Nordfors, A. Rashid Quresh, C. Avesani, P. Barany, et al. 2007. Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism. Nephrology, Dialysis, Transplantation 22: 196–202.PubMedCrossRef Wang, X., J. Axelsson, L. Nordfors, A. Rashid Quresh, C. Avesani, P. Barany, et al. 2007. Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism. Nephrology, Dialysis, Transplantation 22: 196–202.PubMedCrossRef
25.
go back to reference Dummer, C.D., F.S. Thomé, and F.V. Veronese. 2007. Doença renal crônica, inflamação e aterosclerose: novos conceitos de um velho problema. Revista da Associação Médica Brasileira 53: 446–450.PubMedCrossRef Dummer, C.D., F.S. Thomé, and F.V. Veronese. 2007. Doença renal crônica, inflamação e aterosclerose: novos conceitos de um velho problema. Revista da Associação Médica Brasileira 53: 446–450.PubMedCrossRef
26.
go back to reference Nascimento, M.M., M.E. Suliman, M. Silva, et al. 2010. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Peritoneal Dialysis International 30: 336–342.PubMedCrossRef Nascimento, M.M., M.E. Suliman, M. Silva, et al. 2010. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Peritoneal Dialysis International 30: 336–342.PubMedCrossRef
27.
go back to reference Witasp, A., J.J. Carrero, O. Heimbürger, B. Lindholm, F. Hammarqviso, P. Stenvinkel, et al. 2011. Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients. Internal Medicine 269: 410–419.CrossRef Witasp, A., J.J. Carrero, O. Heimbürger, B. Lindholm, F. Hammarqviso, P. Stenvinkel, et al. 2011. Increased expression of pro-inflammatory genes in abdominal subcutaneous fat in advanced chronic kidney disease patients. Internal Medicine 269: 410–419.CrossRef
Metadata
Title
Association of Body Fat with Inflammation in Peritoneal Dialysis
Authors
Andresa Marques de Mattos
Paula Payão Ovidio
Alceu Afonso Jordão
José Abrão Cardeal da Costa
Paula Garcia Chiarello
Publication date
01-06-2013
Publisher
Springer US
Published in
Inflammation / Issue 3/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-013-9593-3

Other articles of this Issue 3/2013

Inflammation 3/2013 Go to the issue